Sandoz AG, headquartered in Basel, Switzerland, is a global leader in the development and manufacturing of drug delivery devices. The company specializes in innovative solutions such as inhalers and advanced pharmaceutical formulations, focusing on enhancing the stability and efficacy of therapeutic compositions. Sandoz is committed to advancing drug delivery technologies, including the use of microparticles and recombinant proteins, to improve patient outcomes and accessibility to essential medications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

149 Patents

#11 in Basel

#123 in Switzerland

#5,484 in the World

Basel, Switzerland

Sandoz Ag

Forward Citations = 315

237 inventors:

Johannes Ludescher (19 out of 57 patents)

Hubert Sturm (17 out of 32 patents)

Josef Wieser (13 out of 25 patents)

4. Ulrich Griesser (12 out of 14 patents)

5. Franz Xaver Schwarz (11 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sandoz Ag. Retrieved from https://idiyas.com/company/sandoz-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

34 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

141 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]